Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Krüppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer

Cancer Gene Therapy volume 24, pages 361–366 (2017)Cite this article

Subjects

Abstract

Sijunzi decoction (SJZD) is a traditional Chinese medicine prescription for the prevention and treatment of colorectal cancer. Our study is aimed to identify the potential therapeutic target of SJZD. Microarray analysis was performed on the patients with colorectal cancer under treatment of SJZD. The mRNA targets of SJZD were predicted by BATMAN-TCM database and were further identified by integrated analysis of expression data from TCGA. The correlation of gene expression and clinical characteristics was analyzed. Microarray analysis indicated that Krüppel-like factor 4 (KLF4) was significantly upregulated after intervention of SJZD. BATMAN-TCM prediction showed that KLF4 was an mRNA target of SJZD and it was downregulated in colorectal cancer by integrated analysis of expression data from TCGA. KLF4 may act as an administered indicator to assess whether adjuvant postoperative pharmaceutical therapy is needed for patients with colorectal cancer. Low KLF4 expression was significantly correlated with reductions of overall survival and recurrence rate. Our results suggested that KLF4 may be the potential therapeutic target of SJZD for the treatment of colorectal cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Stiefelhagen P . Prevention of colon carcinoma. Can herbal medicine prevent colon cancer? MMW Fortschr Med 2012; 154: 24.

    PubMed  Google Scholar 

  2. An K, Jin-Rui G, Zhen Z, Xiao-Long W . Simultaneous quantification of ten active components in traditional Chinese formula Sijunzi Decoction using a UPLC-PDA method. J Anal Methods Chem 2014; 2014: 570359.

    Article  Google Scholar 

  3. Hsiao WL, Liu L . The role of traditional Chinese herbal medicines in cancer therapy—from TCM theory to mechanistic insights. Planta Med 2010; 76: 1118–1131.

    Article  CAS  Google Scholar 

  4. Liu Y, Yang J, Cai Z . Chemical investigation on Sijunzi decoction and its two major herbs Panax ginseng and Glycyrrhiza uralensis by LC/MS/MS. J Pharm Biomed Anal 2006; 41: 1642–1647.

    Article  CAS  Google Scholar 

  5. Liu L, Han L, Wong DY, Yue PY, Ha WY, Hu YH et al. Effects of Si-Jun-Zi decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells. Br J Nutr 2005; 93: 21–29.

    Article  CAS  Google Scholar 

  6. Guo JH, Chen G, Yang SQ, Wei MH, Chen X . Clinical observation of the role of Chenxia Sijunzi decoction in promoting the recovery of gastrointestinal function in critically ill patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012; 24: 674–676.

    PubMed  Google Scholar 

  7. Lu Y, Lin H, Zhang J, Wei J, Sun J, Han L . Sijunzi decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-kappaB pathway in Caco2 cells. BMC Complement Altern Med 2017; 17: 35.

    Article  Google Scholar 

  8. Wang Z, Peng Y, Li XB . Effect of Sijunzi decoction on the intestinal flora disturbance in two rat models of Pi-deficiency syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009; 29: 825–829.

    CAS  PubMed  Google Scholar 

  9. Liang C, Zhang SH, Cai ZD . Effects of early intestinal application of sijunzi decoction on immune function in post-operational patients of gastrointestinal tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25: 1070–1073.

    PubMed  Google Scholar 

  10. Wang L, Jiang Q, Hu J, Zhang Y, Li J . Research Progress on Chemical Constituents of Lonicerae japonicae flos. Biomed Res Int 2016; 2016: 8968940.

    PubMed  PubMed Central  Google Scholar 

  11. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A . GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 2012; 40 (Web Server issue): W478–W483.

    Article  CAS  Google Scholar 

  12. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25–29.

    Article  CAS  Google Scholar 

  13. Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27–30.

    Article  CAS  Google Scholar 

  14. Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H et al. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Sci Rep 2016; 6: 21146.

    Article  CAS  Google Scholar 

  15. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.

    Article  Google Scholar 

  16. Chen M, May BH, Zhou IW, Xue CC, Zhang AL . Meta-analysis of oxaliplatin-based chemotherapy combined with traditional medicines for colorectal cancer: contributions of specific plants to tumor response. Integr Cancer Ther 2016; 15: 40–59.

    Article  Google Scholar 

  17. Sagar SM, Wong RK . Chinese medicine and biomodulation in cancer patients—part one. Curr Oncol 2008; 15: 42–48.

    Article  CAS  Google Scholar 

  18. Shields JM, Christy RJ, Yang VW . Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 1996; 271: 20009–20017.

    Article  CAS  Google Scholar 

  19. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW . Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 2005; 15: 92–96.

    Article  CAS  Google Scholar 

  20. McConnell BB, Ghaleb AM, Nandan MO, Yang VW . The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007; 29: 549–557.

    Article  CAS  Google Scholar 

  21. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW . Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004; 23: 395–402.

    Article  CAS  Google Scholar 

  22. Yu T, Chen X, Zhang W, Li J, Xu R, Wang TC et al. Kruppel-like factor 4 regulates intestinal epithelial cell morphology and polarity. PLoS ONE 2012; 7: e32492.

    Article  CAS  Google Scholar 

  23. Chen YS, Wang R, Dashwood WM, Lohr CV, Williams DE, Ho E et al. A miRNA signature for an environmental heterocyclic amine defined by a multi-organ carcinogenicity bioassay in the rat. Arch Toxicol 2017 (e-pub ahead of print; doi: 10.1007/s00204-017-1945-6).

  24. Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN, Wu M . Down-regulation of gut-enriched Kruppel-like factor expression in esophageal cancer. World J Gastroenterol 2002; 8: 966–970.

    Article  CAS  Google Scholar 

  25. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005; 65: 2746–2754.

    Article  CAS  Google Scholar 

  26. Choi BJ, Cho YG, Song JW, Kim CJ, Kim SY, Nam SW et al. Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract 2006; 202: 585–589.

    Article  CAS  Google Scholar 

  27. Stone CD, Chen ZY, Tseng CC . Gut-enriched Kruppel-like factor regulates colonic cell growth through APC/beta-catenin pathway. FEBS Lett 2002; 530: 147–152.

    Article  CAS  Google Scholar 

  28. Zhang W, Chen X, Kato Y, Evans PM, Yuan S, Yang J et al. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 2006; 26: 2055–2064.

    Article  CAS  Google Scholar 

  29. Ghaleb AM, Elkarim EA, Bialkowska AB, Yang VW . KLF4 suppresses tumor formation in genetic and pharmacological mouse models of colonic tumorigenesis. Mol Cancer Res 2016; 14: 385–396.

    Article  CAS  Google Scholar 

  30. Xu J, Lu B, Xu F, Gu H, Fang Y, Huang Q et al. Dynamic down-regulation of Kruppel-like factor 4 in colorectal adenoma-carcinoma sequence. J Cancer Res Clin Oncol 2008; 134: 891–898.

    Article  CAS  Google Scholar 

  31. Lee HY, Ahn JB, Rha SY, Chung HC, Park KH, Kim TS et al. High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients. World J Surg Oncol 2014; 12: 232.

    Article  Google Scholar 

  32. Patel NV, Ghaleb AM, Nandan MO, Yang VW . Expression of the tumor suppressor Kruppel-like factor 4 as a prognostic predictor for colon cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 2631–2638.

    Article  CAS  Google Scholar 

  33. Ghaleb AM, Laroui H, Merlin D, Yang VW . Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-kappaB pathway inflammatory response. Inflamm Bowel Dis 2014; 20: 811–820.

    Article  Google Scholar 

  34. Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen J et al. Kruppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLoS ONE 2013; 8: e56082.

    Article  CAS  Google Scholar 

  35. Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol 2015; 33: 306–312.

    Article  CAS  Google Scholar 

  36. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL et al. The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res 2013; 73: 4372–4382.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Natural Science Foundation of Xinjiang Uygur Autonomous Region (2012211A094).

Author information

Authors and Affiliations

  1. Radiotherapy Center, Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, China

    Y Jie

  2. Department of Oncology No. 2, Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, China

    W He

  3. Department of Anorectal, Urumqi City Hospital of Traditional Chinese Medicine, Urumqi, China

    X Yang

  4. Department of Anorectal, Hospital (TCM) Affiliated to Southwest Medical University, Luzhou, China

    W Chen

Authors
  1. Y Jie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Chen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Cancer Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jie, Y., He, W., Yang, X. et al. Krüppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer. Cancer Gene Ther 24, 361–366 (2017). https://doi.org/10.1038/cgt.2017.25

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2017.25

This article is cited by

Search

Advanced search

Quick links